Based on the provided data, hospital discharges for malignant neoplasm of the prostate in Poland stood at 14.6 thousand in 2024. This figure is projected to rise steadily over the next few years, reaching 16.17 thousand by 2028. This indicates a consistent year-on-year increase: 2.67% from 2024 to 2025, 2.67% from 2025 to 2026, 2.53% from 2026 to 2027, and 2.47% from 2027 to 2028. The compound annual growth rate (CAGR) over this five-year period is approximately 2.58%.
Future trends to watch for include advancements in early detection and treatment technologies, which may influence the hospitalization rates for malignant neoplasms of the prostate. Additionally, demographic shifts such as aging populations and potential changes in healthcare policies could also impact these projections.
